Skip to Main Content

Author Details

Yue Yang
Peking University Cancer Hospital
2005
126
22
PMIDPaper TitleJournal TitlePublished Year
36863124Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial.Lung Cancer2023
37548145Machine learning-based establishment and validation of age-related patterns for predicting prognosis in non-small cell lung cancer within the context of the tumor microenvironment.IUBMB Life2023
37261804Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial.JAMA Oncol2023
35060694A Dual-Channel Intelligent Point-of-Care Testing System for Soluble Programmed Death-1 and Programmed Death-Ligand 1 Detection Based on Folding Paper-Based Immunosensors.ACS Sens2022
35733338CRISPR-mediated MECOM depletion retards tumor growth by reducing cancer stem cell properties in lung squamous cell carcinoma.Mol Ther2022
35399576Intermittent chest tube clamping decreases chest tube duration time and drainage volume after lung cancer surgery in patients without air leak: an open-label, randomized controlled trial.Transl Lung Cancer Res2022
35371319circ_0000567/miR-421/<i>TMEM100</i> Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis.J Cancer2022
35358776Multifunctional self-driven origami paper-based integrated microfluidic chip to detect CRP and PAB in whole blood.Biosens Bioelectron2022
36248334International expert consensus on immunotherapy for early-stage non-small cell lung cancer.Transl Lung Cancer Res2022
36027483Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non-Small-Cell Lung Cancer.J Clin Oncol2022
34913597Neoadjuvant PD-1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung.Thorac Cancer2022
35275522MiR-224 promotes lymphatic metastasis by targeting ANGPTL1 in non-small-cell lung carcinoma.Cancer Biomark2022
35211858Percentage of Newly Proposed High-Grade Patterns Is Associated with Prognosis of Pathological T1-2N0M0 Lung Adenocarcinoma.Ann Surg Oncol2022
35240162PTPIP51 inhibits non-small-cell lung cancer by promoting PTEN-mediated EGFR degradation.Life Sci2022
33389296Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer.Ann Surg Oncol2021
33880525High-risk-pattern lung adenocarcinoma with epidermal growth factor receptor mutation is associated with distant metastasis risk and may benefit from adjuvant targeted therapy.Interact Cardiovasc Thorac Surg2021
33787090Clinical recommendations for perioperative immunotherapy-induced adverse events in patients with non-small cell lung cancer.Thorac Cancer2021
33819964[Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi2021
33707423Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer.Cell Death Dis2021
33500522An origami paper-based nanoformulated immunosensor detects picograms of VEGF-C per milliliter of blood.Commun Biol2021
33747909Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer.Front Oncol2021
34703647HIF1A-AS2 induces osimertinib resistance in lung adenocarcinoma patients by regulating the miR-146b-5p/IL-6/STAT3 axis.Mol Ther Nucleic Acids2021
34703281Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer.Int J Gen Med2021
34253867Major pathologic response assessment and clinical significance of metastatic lymph nodes after neoadjuvant therapy for non-small cell lung cancer.Mod Pathol2021
31503013Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma.Anticancer Drugs2020
35117517The prognostic analysis of lung cancer patients with occult malignant pleural disease at thoracotomy.Transl Cancer Res2020
34567646Low sample volume origami-paper-based graphene-modified aptasensors for label-free electrochemical detection of cancer biomarker-EGFR.Microsyst Nanoeng2020
33209366Does neoadjuvant targeted therapy provide an opportunity for resectable EGFR-mutant lung cancer: a real-world retrospective study.J Thorac Dis2020
32604042Deep learning combined with radiomics may optimize the prediction in differentiating high-grade lung adenocarcinomas in ground glass opacity lesions on CT scans.Eur J Radiol2020
32175416Recommended changes for the 8th edition of the TNM classification for lung cancer-the findings of a single-institution evaluation.Ann Transl Med2020
32175415External validation of the eighth edition of the TNM classification for lung cancer in 3,611 surgically treated patients at a single institution.Ann Transl Med2020
32227277Impact of Early Oral Feeding on Anastomotic Leakage Rate After Esophagectomy: A Systematic Review and Meta-analysis.World J Surg2020
30408570Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement.J Thorac Oncol2019
35116879Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome.Transl Cancer Res2019
31801598Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.J Exp Clin Cancer Res2019
31771739[Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi2019
31559065Comparison of Ivor Lewis esophagectomy and Sweet esophagectomy for the treatment of middle-lower esophageal squamous cell carcinoma.J Thorac Dis2019
31305128Distinct Molecular Mechanisms Analysis of Three Lung Cancer Subtypes Based on Gene Expression Profiles.J Comput Biol2019
31039491Label-free microfluidic paper-based electrochemical aptasensor for ultrasensitive and simultaneous multiplexed detection of cancer biomarkers.Biosens Bioelectron2019
30858729Impact of preoperative exercise therapy on surgical outcomes in lung cancer patients with or without COPD: a systematic review and meta-analysis.Cancer Manag Res2019
30799956Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study.Cancer Manag Res2019
30764882Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition).J Hematol Oncol2019
31109440[Expression of MiR-148b-3p in Lung Adenocarcinoma and Its Correlation with Prognosis].Zhongguo Fei Ai Za Zhi2019
30391781Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.Cancer Lett2019
30474757Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.J Cancer Res Clin Oncol2019
29341464Left sleeve lobectomy versus left pneumonectomy for the management of patients with non-small cell lung cancer.Thorac Cancer2018
30075575Tumor size and lymph node metastasis are prognostic markers of small cell lung cancer in a Chinese population.Medicine (Baltimore)2018
30150014Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial.Lancet Respir Med2018
30349307MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial-mesenchymal transition in lung cancer cells.Onco Targets Ther2018
30700927Adjuvant chemotherapy may improve outcome of patients with non-small-cell lung cancer with metastasis of intrapulmonary lymph nodes after systematic dissection of N1 nodes.Chin J Cancer Res2018
  • 1 - 50 of 126

Recommended Authors

Zisheng Chen
The Sixth Affiliated Hospital of Guangzhou Medical University
Career Start Year 2018
Number of shared co-authors 3
Hengrui Liang
The First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2017
Number of shared co-authors 3
Yi Zhao
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2013
Number of shared co-authors 3
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 1
Yin Guan
DHC Technologies Co. Ltd.
Career Start Year 2008
Number of shared co-authors 0
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 0
Li Liu
Central South University
Career Start Year 2006
Number of shared co-authors 0
Jun Huang
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2006
Number of shared co-authors 3
Bhumsuk Keam
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 0
Chi Young Jung
Daegu Catholic University Medical Center
Career Start Year 2006
Number of shared co-authors 0
Fei Cui
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2005
Number of shared co-authors 4
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Jane Yanagawa
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Haitao Lan
Academy of Medical Sciences, Sichuan Provincial People's Hospital
Career Start Year 2003
Number of shared co-authors 0
Yun Li
Peking University People's Hospital
Career Start Year 2002
Number of shared co-authors 1
Daniel Morgensztern
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Career Start Year 1998
Number of shared co-authors 0
Prudence A Russell
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 0
Ping Yang
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 2
Young Mog Shim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Liyan Xue
Xuzhou Central Hospital
Career Start Year 1996
Number of shared co-authors 1
Gavin M Wright
St. Vincent's Hospital, University of Melbourne
Career Start Year 1995
Number of shared co-authors 2
Jae Ill Zo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 0
Gail Darling
University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Nasser K Altorki
New York-Presbyterian Hospital
Career Start Year 1983
Number of shared co-authors 1
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 0
David H Harpole
Duke University Medical Center
Career Start Year 1962
Number of shared co-authors 0

Collaborators

Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Co-authored papers 57
Shi Yan
Qilu Hospital of Shandong University
Co-authored papers 46
Shaolei Li
Peking University Cancer Hospital & Institute
Co-authored papers 46
Xing Wang
Shanghai Children's Hospital, Shanghai Jiao Tong University
Co-authored papers 17
Jianxing He
Guangzhou Medical University, First Hospital
Co-authored papers 6
Fang Fang
Co-authored papers 5
Xin Yang
Peking University Cancer Hospital & Institute
Co-authored papers 5
Huanming Yang
Experimental Research Center, China Academy of Chinese Medical Sciences
Co-authored papers 2
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Co-authored papers 2
Jian-Jun Wang
Institute for Brain Sciences, Nanjing University
Co-authored papers 1
Quanzheng Li
Massachusetts General Hospital
Co-authored papers 1
Lei Tang
Peking University Cancer Hospital and Institute
Co-authored papers 1
Jie Zhao
Center for Data Science in Health and Medicine, Peking University
Co-authored papers 1
Gaoxiang Chen
Center for Data Science, Peking University
Co-authored papers 1
Hong-Zhi Wang
Peking University Cancer Hospital & Institute
Co-authored papers 1
Yue Kang
Co-authored papers 1
Li Zhang
Chang'an University
Co-authored papers 1
Wenhua Liang
The First People's Hospital of Zhaoqing
Co-authored papers 1
Xin Yu
Peking University Sixth Hospital, Peking University Institute of Mental Health
Co-authored papers 1
Xiang Li
Peking University Cancer Hospital & Institute
Co-authored papers 1
Release 1.2